Evercore ISI Group analyst Thomas Gallagher maintains Equitable Holdings (NYSE:EQH) with a Outperform and lowers the price target from $45 to $41.
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
Voyager Therapeutics Inc (NASDAQ:VYGR) unveiled its prioritized therapeutic pipeline focusing on tau antibody for Alzheimer’s disease and gene therapies for GBA1…